“3) All of the naysayers that reject a submission for a NDA using the trial results from Avatar DO NOT have all of the information that the company has. It is pure speculation on their part.”
Excuse me, but speculation is all on those going beyond known facts and that’s a FACT!
Agree. When trial data compiles allowing bigger thoughts for AVXL MOA and CNS disease efficacy then a much more exciting AVXL BO dynamic may develop. Looking forward to developments along this line.